Tumor misdiagnosis resulting in inappropriate use of biologics

Yuki Yoshiyasu; Mason R. Krysinski; Rakesh K. Chandra; Philip G. Chen

doi:10.1002/alr.23381

Tumor misdiagnosis resulting in inappropriate use of biologics

Yuki Yoshiyasu, Mason R. Krysinski, Rakesh K. Chandra, Philip G. Chen

Department of Otolaryngology, Head & Neck Surgery

Producción científica: Letter › revisión exhaustiva

Resumen

Key points: Unilateral or destructive sinonasal disease should raise suspicion for tumor. Patients receiving biologic therapy for CRSwNP should be carefully selected. Tissue diagnosis should be considered prior to starting biologics for nasal polyposis.

Idioma original	English (US)
Publicación	International Forum of Allergy and Rhinology
DOI	https://doi.org/10.1002/alr.23381
Estado	Accepted/In press - 2024

ASJC Scopus subject areas

Immunology and Allergy
Otorhinolaryngology

Acceder al documento

10.1002/alr.23381

Otros archivos y enlaces

Citar esto

@article{9ea3e7d886c344e1bc7deb236e6b7c42,

title = "Tumor misdiagnosis resulting in inappropriate use of biologics",

abstract = "Key points: Unilateral or destructive sinonasal disease should raise suspicion for tumor. Patients receiving biologic therapy for CRSwNP should be carefully selected. Tissue diagnosis should be considered prior to starting biologics for nasal polyposis.",

keywords = "biologic therapy, chronic rhinosinusitis, CRSwNP, nasal polyposis, sinonasal tumor",

author = "Yuki Yoshiyasu and Krysinski, {Mason R.} and Chandra, {Rakesh K.} and Chen, {Philip G.}",

note = "Publisher Copyright: {\textcopyright} 2024 ARS-AAOA, LLC.",

year = "2024",

doi = "10.1002/alr.23381",

language = "English (US)",

journal = "International Forum of Allergy and Rhinology",

issn = "2042-6976",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Tumor misdiagnosis resulting in inappropriate use of biologics

AU - Yoshiyasu, Yuki

AU - Krysinski, Mason R.

AU - Chandra, Rakesh K.

AU - Chen, Philip G.

PY - 2024

Y1 - 2024

N2 - Key points: Unilateral or destructive sinonasal disease should raise suspicion for tumor. Patients receiving biologic therapy for CRSwNP should be carefully selected. Tissue diagnosis should be considered prior to starting biologics for nasal polyposis.

AB - Key points: Unilateral or destructive sinonasal disease should raise suspicion for tumor. Patients receiving biologic therapy for CRSwNP should be carefully selected. Tissue diagnosis should be considered prior to starting biologics for nasal polyposis.

KW - biologic therapy

KW - chronic rhinosinusitis

KW - CRSwNP

KW - nasal polyposis

KW - sinonasal tumor

UR - http://www.scopus.com/inward/record.url?scp=85195507677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85195507677&partnerID=8YFLogxK

U2 - 10.1002/alr.23381

DO - 10.1002/alr.23381

M3 - Letter

C2 - 38853636

AN - SCOPUS:85195507677

SN - 2042-6976

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

ER -

Tumor misdiagnosis resulting in inappropriate use of biologics

Resumen

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto